Vaccines for the Future Act of 2007
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
73pct
37d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2008 · first_quarter · Health Issues
S. 2029, Physician Payments Sunshine Act of 2007, Issues related to medical device company/physician relationship H.R. 5605, Physican Payments Sunshine Act of 2008, Issues related to medical device company/physician relationship S. 2467, A bill to amend the Social Security Act, the Federal Food, Drug, and Cosmetic Act, and the Pubic Health Service Act to ensure a sufficient supply of vaccines, and for other purchases. Issues related to vaccine delivery H.R. 4703, Vaccine Shortage Preparedness Act of 2008, Issues related to vaccine delivery S. 2466, A bill to amend the Public Health Service Act to increase the availability of vaccines, and for other purposes, Issues related to vaccine delivery H.R. 4705, Vaccines for the Uninsured Adult Act of 2008, Issues related to vaccine delivery S. 2221, Transparency in Medical Device Pricing Act of 2007, Issues relating to disclosure of pricing information for specified categories of products S. 569, Vaccines for the Future Act of 2007, Issues related to vaccine delivery H.R. 1391, Vaccines for the Future Act of 2007, Issues related to vaccine delivery H.R. 5501, To authorize appropriations for fiscal years 2009 through 2013 to provide assistance to foreign countries to combat HIV/AIDS, tuberculosis, and malaria, and for other purposes, Issues related to HIV/AIDS and Tuberculosis S. 968, Stop Tuberculosis (TB) Now Act of 2007, Issues related to tuberculosis prevention and treatment H.R. 1567, Stop Tuberculosis (TB) Now Act of 2007, Issues related to tuberculosis prevention and treatment
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $250,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2008 · first_quarter · Health Issues
S. 242 Pharmaceutical Market Access and Drug Safety Act of 2007 H.R. 380 Pharmaceutical Market Access and Drug Safety Act of 2007 S. 2456 Influenza Vaccine Security Act of 2007 H.R. 881 Mercury-Free Vaccines Act of 2007 H.R. 4703 Vaccine Shortage Preparedness Act of 2008 S. 2467 Vaccine Shortage Preparedness Act of 2008 H.R. 4705 Vaccines for the Uninsured Adult Act of 2007 H.R. 1391 Vaccines for the Future Act of 2007 S. 569 Vaccines for the Future Act of 2007 H.R. 4704 Medicare Improvement Act of 2007 S. 2464 Medicare Improvement Act of 2007 S. 2476 Improved Vaccines Supply Act H.R. 3944 National Hepatitis B Act
Client expense: $1,240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2007 · year_end · Medical/Disease Research/Clinical Labs
H.R. 3697, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention S. 2313, Strategies to Address Antimicrobial Resistance Act, Issues relating to HAI/MRSA surveillance and prevention H.R. 1391, Vaccines for the Future Act, Issues relating to vaccine development
Client expense: $740,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Foreign Relations
H.R. 1391 and S. 569, to accelerate efforts to develop vaccines for diseases primarily affecting developing countries and for other purposes. Issues related to advanced market commitments for vaccines.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)
2007 · mid_year · Foreign Relations
H.R. 1391 and S. 569, to accelerate efforts to develop vaccines for diseases primarily affecting developing countries and for other purposes. Issues related to advanced market commitments for vaccines.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)
| Democratic |
| NY |
| Barbara Lee | Democratic | CA |
| Betty Sutton | Democratic | OH |
| Bob Filner | Democratic | CA |
| Brian Higgins | Democratic | NY |
| Carol Shea-Porter | Democratic | NH |
| Charles B. Rangel | Democratic | NY |
| Chris Van Hollen | Democratic | MD |
| Corrine Brown | Democratic | FL |
| Donald Payne | Democratic | NJ |
| Donna M. Christensen | Democratic | VI |
| Earl Blumenauer | Democratic | OR |
| Ed Pastor | Democratic | AZ |
| Eleanor Holmes Norton | Democratic | DC |
| Elijah E. Cummings | Democratic | MD |
| Henry A. Waxman | Democratic | CA |
| Howard L. Berman | Democratic | CA |
| James P. McGovern | Democratic | MA |
| Jane Harman | Democratic | CA |
| Janice D. Schakowsky | Democratic | IL |
| Jerrold Nadler | Democratic | NY |
| Jesse L. Jackson Jr. | Democratic | IL |
| Jim McDermott | Democratic | WA |
| John Conyers, Jr. | Democratic | MI |
| John F. Tierney | Democratic | MA |
| Julia Carson | Democratic | IN |
| Lois Capps | Democratic | CA |
| Louise McIntosh Slaughter | Democratic | NY |
| Lynn C. Woolsey | Democratic | CA |
| Mark Souder | Republican | IN |
| Maxine Waters | Democratic | CA |
| Michael E. Capuano | Democratic | MA |
| Michael McNulty | Democratic | NY |
| Paul Hodes | Democratic | NH |
| Peter T. King | Republican | NY |
| Raúl M. Grijalva | Democratic | AZ |
| Sheila Jackson Lee | Democratic | TX |
| Steve Israel | Democratic | NY |
| Thaddeus McCotter | Republican | MI |
| Thomas Allen | Democratic | ME |
| Zoe Lofgren | Democratic | CA |